Posts by: Joana Carvalho

News

Oral morphine treatment is a valid therapy option for patients with sickle cell disease (SCD) who are undergoing a vaso-occlusive crisis (VOC), researchers suggest. It was found to significantly reduce ... Read more

March 12, 2019March 12, 2019

Weight-loss Surgery May Help Reduce VOCs in Morbidly Obese SCD Patients

News

Bariatric surgery may help reduce the rates of vaso-occlusive crises (VOCs) in morbidly obese patients with sickle cell disease (SCD) without increasing the risk of mortality or other adverse events, a ... Read more

March 5, 2019March 5, 2019

Differences in Brain Oxygen Supply May Explain Silent Strokes in SCD Patients

News

Brain oxygen supply is different in different regions of the brain of sickle cell disease (SCD) patients who are affected by anemia, which may explain the incidence of silent strokes, ... Read more

February 12, 2019February 19, 2019

ATS Releases Guidelines for Home Oxygen Therapy in Children with Sickle Cell Disease

News

The American Thoracic Society (ATS) released a set of new guidelines for home oxygen therapy for children with chronic health conditions that cause a reduction in blood oxygen levels, ... Read more

January 10, 2019January 11, 2019

Crizanlizumab Designated FDA Breakthrough Therapy for Potential in Vaso-occlusive Crisis Prevention

News

Crizanlizumab (SEG101), Novartis‘ investigational compound for sickle cell disease (SCD), received breakthrough therapy designation from the U.S. Food and Drug Administration for its potential to prevent vaso-occlusive crises (VOCs). The FDA ... Read more

September 4, 2018September 4, 2018

Altemia Shows Promising Results in Phase 2 Trial for SCD Children

News

Sancilio Pharmaceuticals‘ investigational oral compound Altemia (SC411) shows promising results in treating children with sickle cell disease (SCD), a Phase 2 clinical trial reveals. The study, “Double-blind, randomized, multicenter ... Read more

Posts by: Joana Carvalho

Joana Carvalho

Oral Morphine is a Viable Treatment Option for SCD Patients Experiencing VOCs, Study Says

Weight-loss Surgery May Help Reduce VOCs in Morbidly Obese SCD Patients

Differences in Brain Oxygen Supply May Explain Silent Strokes in SCD Patients

ATS Releases Guidelines for Home Oxygen Therapy in Children with Sickle Cell Disease

Crizanlizumab Designated FDA Breakthrough Therapy for Potential in Vaso-occlusive Crisis Prevention

Altemia Shows Promising Results in Phase 2 Trial for SCD Children

Pin It on Pinterest